Financhill
Buy
69

PMCUF Quote, Financials, Valuation and Earnings

Last price:
$161.98
Seasonality move :
9.25%
Day range:
$161.98 - $161.98
52-week range:
$58.67 - $171.93
Dividend yield:
0.16%
P/E ratio:
304.62x
P/S ratio:
160.21x
P/B ratio:
134.80x
Volume:
100
Avg. volume:
171
1-year change:
154.57%
Market cap:
$16.9B
Revenue:
$105.8M
EPS (TTM):
$0.52

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Pro Medicus has -- downside to fair value with a price target of -- per share.

PMCUF vs. S&P 500

  • Over the past 5 trading days, Pro Medicus has overperformed the S&P 500 by 1.96% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Pro Medicus does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Pro Medicus has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Pro Medicus reported revenues of --.

Earnings Growth

  • Pro Medicus has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Pro Medicus reported earnings per share of --.
Enterprise value:
16.8B
EV / Invested capital:
--
Price / LTM sales:
160.21x
EV / EBIT:
228.54x
EV / Revenue:
158.86x
PEG ratio (5yr expected):
4.50x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
212.44x
Gross Profit (TTM):
$105.6M
Return On Assets:
36.05%
Net Income Margin (TTM):
51.3%
Return On Equity:
49.99%
Return On Invested Capital:
49.83%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-21 2024-01-21 2024-01-21
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Balance Sheet
Current Assets $42.2M $65.8M $82.4M $108.4M $138.1M
Total Assets $65.7M $94.3M $108M $133.8M $172.1M
Current Liabilities $8.7M $13.2M $18.5M $20.4M $23.1M
Total Liabilities $24.4M $33M $38.1M $41.9M $46.6M
Total Equity $41.4M $61.4M $70M $91.9M $125.5M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-21 2024-01-21 2024-01-21
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
PMCUF
Sector
Market Cap
$16.9B
$44.9M
Price % of 52-Week High
94.21%
46.55%
Dividend Yield
0.16%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
154.57%
-33.54%
Beta (5-Year)
1.228
0.746
Dividend yield:
0.16%
Annualized payout:
$0.23
Payout ratio:
44.13%
Growth streak:
4 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $156.40
200-day SMA
Buy
Level $107.45
Bollinger Bands (100)
Buy
Level 111.34 - 154.06
Chaikin Money Flow
Buy
Level 68.7K
20-day SMA
Buy
Level $157.43
Relative Strength Index (RSI14)
Buy
Level 62.46
ADX Line
Buy
Level 24.22
Williams %R
Sell
Level -8.7031
50-day SMA
Buy
Level $149.74
MACD (12, 26)
Buy
Level 1.38
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level 191K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (128.7676)
Buy
CA Score (Annual)
Level (2.941)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-4.912)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Pro Medicus is a healthcare IT company specialising in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Stock Forecast FAQ

In the current month, PMCUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PMCUF average analyst price target in the past 3 months is --.

  • Where Will Pro Medicus Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Pro Medicus share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Pro Medicus?

    Analysts are divided on their view about Pro Medicus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pro Medicus is a Sell and believe this share price will rise from its current level to --.

  • What Is Pro Medicus's Price Target?

    The price target for Pro Medicus over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PMCUF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Pro Medicus is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PMCUF?

    You can purchase shares of Pro Medicus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pro Medicus shares.

  • What Is The Pro Medicus Share Price Today?

    Pro Medicus was last trading at $161.98 per share. This represents the most recent stock quote for Pro Medicus. Yesterday, Pro Medicus closed at $161.98 per share.

  • How To Buy Pro Medicus Stock Online?

    In order to purchase Pro Medicus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Trump Presidency Means For Stock Market
What Trump Presidency Means For Stock Market

Donald Trump was the first president in modern U.S. history…

Where Will TJX Companies Stock Be in 10 Years?
Where Will TJX Companies Stock Be in 10 Years?

Off-price retail is as popular as ever thanks to social…

Will CVS Health Stock Recover?
Will CVS Health Stock Recover?

It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 16

Quantum [QMCO] is down 0% over the past day.

Buy
51
QRVO alert for Jan 16

Qorvo [QRVO] is down 0% over the past day.

Sell
31
ATEX alert for Jan 16

Anterix [ATEX] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock